A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
Clinical trial NCT05822830 · COMPLETED
Trial details
- NCT number
- NCT05822830
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-21
- Primary completion
- 2024-11-13
- Enrollment
- 751
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.